Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2753)
All Articles published online
|
Aug 21, 2009 (publication date) through Jun 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | El Hajj II, Malik SM, Alwakeel HR, Shaikh OS, Sasatomi E, Kandil HM. Celecoxib-induced cholestatic liver failure requiring orthotopic liver transplantation. World J Gastroenterol 2009; 15(31): 3937-3939 [PMID: 19701976 DOI: 10.3748/wjg.15.3937] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i31/3937.htm |
| Number | Citing Articles |
| 1 |
Rachel P. L. van Swelm, Cornelis Kramers, Rosalinde Masereeuw, Frans G. M. Russel. Application of urine proteomics for biomarker discovery in drug-induced liver injury. Critical Reviews in Toxicology 2014; 44(10): 823 doi: 10.3109/10408444.2014.931341
|
| 2 |
Tanvir Haque, Eizaburo Sasatomi, Paul H Hayashi. Drug-Induced Liver Injury: Pattern Recognition and Future Directions. Gut and Liver 2016; 10(1): 27 doi: 10.5009/gnl15114
|
| 3 |
David E. Kleiner. MacSween's Pathology of the Liver. 2024; : 726 doi: 10.1016/B978-0-7020-8228-3.00012-0
|
| 4 |
Sebastian Straube. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2011; 33: 241 doi: 10.1016/B978-0-444-53741-6.00009-X
|
| 5 |
Leihong Wu, Zhichao Liu, Scott Auerbach, Ruili Huang, Minjun Chen, Kristin McEuen, Joshua Xu, Hong Fang, Weida Tong. Integrating Drug’s Mode of Action into Quantitative Structure–Activity Relationships for Improved Prediction of Drug-Induced Liver Injury. Journal of Chemical Information and Modeling 2017; 57(4): 1000 doi: 10.1021/acs.jcim.6b00719
|
| 6 |
John Brooling, Rolando Leal. Secondary Sclerosing Cholangitis: a Review of Recent Literature. Current Gastroenterology Reports 2017; 19(9) doi: 10.1007/s11894-017-0583-8
|
| 7 |
Hong-Mei Zhang, Guang-Chen Liu, Yang-Fang He, Wei Zhou, Ji-Qiu Hou. Liver Injury Induced by the Interaction Between Fluoxetine and Celecoxib: A Case Report and the Literature Review. Iranian Red Crescent Medical Journal 2019; 21(9) doi: 10.5812/ircmj.93271
|
| 8 |
A. P. Pereverzev, O. D. Ostroumova, O. V. Golovina, A. V. Filippova, Е. Е. Pavleeva. NSAID-induced liver damage with cholestasis. Medical alphabet 2021; (23): 37 doi: 10.33667/2078-5631-2021-23-37-48
|
| 9 |
Current World Literature. Current Opinion in Supportive & Palliative Care 2010; 4(2): 111 doi: 10.1097/SPC.0b013e32833a1dfc
|
| 10 |
Fernando Bessone, Nelia Hernandez, Marcelo Gabriel Roma, Ezequiel Ridruejo, Manuel Mendizabal, Inmaculada Medina-Cáliz, Mercedes Robles-Díaz, M. Isabel Lucena, Raúl J. Andrade. Hepatotoxicity induced by coxibs: how concerned should we be?. Expert Opinion on Drug Safety 2016; 15(11): 1463 doi: 10.1080/14740338.2016.1225719
|
| 11 |
Yeon-Hee Yoon, Ji Yoon Kim, Yong Chul Bae, Sung-Wook Nam, Hee-Jung Cho, Suho Lee, Ho Young Chung, Hyun-Shik Lee, Mae-Ja Park. Evaluation of the toxic effects of celecoxib on Xenopus embryo development. Biochemical and Biophysical Research Communications 2018; 501(2): 329 doi: 10.1016/j.bbrc.2018.03.002
|
| 12 |
Alberto Unzueta, Hugo E. Vargas. Nonsteroidal Anti-Inflammatory Drug–Induced Hepatoxicity. Clinics in Liver Disease 2013; 17(4): 643 doi: 10.1016/j.cld.2013.07.009
|
| 13 |
David D. Haines, Balazs Varga, Istvan Bak, Bela Juhasz, Fadia F. Mahmoud, Heybatullah Kalantari, Rudolf Gesztelyi, Istvan Lekli, Attila Czompa, Arpad Tosaki. Summative interaction between astaxanthin, Ginkgo biloba extract (EGb761) and vitamin C in Suppression of respiratory inflammation: a comparison with ibuprofen. Phytotherapy Research 2011; 25(1): 128 doi: 10.1002/ptr.3160
|
| 14 |
Kento Shionoya, Masahiro Kobayashi, Makoto Kako, Sakue Masuda, Makomo Makazu, Kazuya Koizumi. Drug-induced Liver Injury Considered Steroid-resistant and Histologically Diagnosed with Vanishing Bile Duct Syndrome. Internal Medicine 2024; 63(12): 1719 doi: 10.2169/internalmedicine.2427-23
|
| 15 |
Hideaki Taniguchi, Hiraku Fujita, Kohtaro Shibagaki, Masahiko Kushiro, Yuuma Tani, Keita Kobayashi. A case of drug-induced liver injury by celecoxib. Kanzo 2014; 55(9): 537 doi: 10.2957/kanzo.55.537
|
| 16 |
Richard A. Thompson, Emre M. Isin, Yan Li, Lars Weidolf, Ken Page, Ian Wilson, Steve Swallow, Brian Middleton, Simone Stahl, Alison J. Foster, Hugues Dolgos, Richard Weaver, J. Gerry Kenna. In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs. Chemical Research in Toxicology 2012; 25(8): 1616 doi: 10.1021/tx300091x
|
| 17 |
Pavan K. Mukthinuthalapati, Robert J. Fontana, Raj Vuppalanchi, Naga Chalasani, Marwan Ghabril. Celecoxib-induced Liver Injury. Journal of Clinical Gastroenterology 2018; 52(2): 114 doi: 10.1097/MCG.0000000000000888
|
| 18 |
Ramanpreet Kaur, Dhimant Desai, Shantu Amin, Kaisar Raza, Aman Bhalla, Pooja Yadav, Naveen Kaushal. Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis. Molecular and Cellular Biochemistry 2023; 478(3): 621 doi: 10.1007/s11010-022-04532-y
|
| 19 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2010; 19(3) doi: 10.1002/pds.1848
|
| 20 |
Jose M. Pinazo-Bandera, Juan Pedro Toro-Ortiz, Raúl J. Andrade, Miren García-Cortés. Drug-induced cholestasis: causative agents and challenges in diagnosis and management. Exploration of Digestive Diseases 2023; 2(5): 202 doi: 10.37349/edd.2023.00027
|
| 21 |
S Hyder Hussaini, Elizabeth Anne Farrington. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opinion on Drug Safety 2014; 13(1): 67 doi: 10.1517/14740338.2013.828032
|
| 22 |
Makiko Matsumura, Takumi Hirano, Hiroko Kuba, Ryoji Nagamura, Eigo Kojima. A case of acute liver failure induced by Pregabalin and Celecoxib. Kanzo 2019; 60(9): 323 doi: 10.2957/kanzo.60.323
|
| 23 |
Shivakumar Chitturi, Geoffrey C Farrell. Lessons from Lumiracoxib: Are cyclooxygenase‐2 inhibitors less hepatotoxic than non‐selective non‐steroidal anti‐inflammatory drugs?. Journal of Gastroenterology and Hepatology 2012; 27(6): 993 doi: 10.1111/j.1440-1746.2012.07142.x
|
| 24 |
David E. Kleiner. Macsween's Pathology of the Liver. 2018; : 673 doi: 10.1016/B978-0-7020-6697-9.00012-1
|
| 25 |
Shivakumar Chitturi, Geoffrey C. Farrell. Schiff's Diseases of the Liver. 2011; : 703 doi: 10.1002/9781119950509.ch27
|
| 26 |
E. Larrey, S. Patouraux, A. Spreux, C.M. Canivet, T. Piche, A. Tran, R. Anty. Fatal cholestatic hepatitis after a single dose of celecoxib. Clinics and Research in Hepatology and Gastroenterology 2019; 43(5): e82 doi: 10.1016/j.clinre.2018.10.007
|
| 27 |
Paul A Schmeltzer. Drug-Induced Liver Injury Due to Nonsteroidal Anti-inflammatory Drugs. Current Hepatology Reports 2019; 18(3): 294 doi: 10.1007/s11901-019-00477-x
|
| 28 |
Suresh Kumar Nayudu, Shanti Badipatla, Masooma Niazi, Bhavna Balar. Cholestatic Hepatitis with Small Duct Injury Associated with Celecoxib. Case Reports in Medicine 2013; 2013: 1 doi: 10.1155/2013/315479
|
| 29 |
Naglaa Zakaria Helmy Eleiwa, Hesham Ahmed M. Ismael Khalifa, Heba Ahmed Nazim. Research progress on rat model of drug-induced liver injury established by nonsteroidal anti-inflammatory drug (celecoxib) and royal jelly ameliorative effect. Journal of Complementary and Integrative Medicine 2024; 0(0) doi: 10.1515/jcim-2023-0385
|